Figure 2
![Figure 2. Plasma ADMA levels in polycythemia vera patients. Plasma ADMA levels in the entire patient population (n = 37), divided according to the ongoing treat-ment (aspirin [ASA] alone, aspirin plus phlebothomy [Phl], or plus hydroxyurea [HU], as well as in healthy controls (n = 12). ● represents patients with previous thrombotic events.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/112/4/10.1182_blood-2007-11-123091/6/zh80170822910002.jpeg?Expires=1736045868&Signature=2A8o2yt-qi5YzQkUGOambgD5KsaaylV0hAHfmSiQ3zJ6N9zRQWFea-utaR02VR1F3eTWnLWl-MklrdRNpfds9zPSPwJ4UDuDJArVlBxcvg8nZN1c8qCQBDKdzJmOyV053oAfMHrCcyp~ABK2zich0xWKWFV1VsSZjRDNEBb8PPpF65vaD4z2HUCPyhb81mfa6YKdV9LlGZQU5yY6thpdDpjfcshf3uSeDkVgClAZTNEXmMCpH8y4czxCG2xHrImFeJk1z8FQSUO5m-8f8jgqToBDKjhcLvqIJGH29Sc7eL8tKQisFBlAmf7yqpXjk-r2oZxQOJa1CxTvV8karPEzWw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Plasma ADMA levels in polycythemia vera patients. Plasma ADMA levels in the entire patient population (n = 37), divided according to the ongoing treat-ment (aspirin [ASA] alone, aspirin plus phlebothomy [Phl], or plus hydroxyurea [HU], as well as in healthy controls (n = 12). ● represents patients with previous thrombotic events.
